中华外科杂志
中華外科雜誌
중화외과잡지
CHINESE JOURNAL OF SURGERY
2013年
8期
696-700
,共5页
于洋%周岩冰%刘汉成%曹守根%张坚%王智浩
于洋%週巖冰%劉漢成%曹守根%張堅%王智浩
우양%주암빙%류한성%조수근%장견%왕지호
胃肿瘤%胰岛素抵抗%碳水化合物%线粒体
胃腫瘤%胰島素牴抗%碳水化閤物%線粒體
위종류%이도소저항%탄수화합물%선립체
Stomach neoplasms%Insulin resistance%Carbohydrates%Mitochondrial
目的 评价胃癌患者术前口服碳水化合物对术后胰岛素抵抗的影响并探讨其可能机制.方法 将2011年4-10月连续入院且符合入组标准的60例胃癌患者按照随机双盲原则分为口服碳水化合物组和口服安慰剂组,术前4h监测患者静息能量消耗(REE)及呼吸商,并抽取空腹血,测定血糖、胰岛素及三酰甘油,麻醉前2~3h口服500 ml碳水化合物(或安慰剂),2组患者均在硬膜外加静脉复合全身麻醉下行根治性远端胃癌切除术,开腹即刻及关腹前取腹直肌组织并固定,术后即刻抽血测定血糖、胰岛素及三酰甘油,并监测术后REE及呼吸商,比较2组患者手术前后胰岛素抵抗指数、三酰甘油、REE及呼吸商的变化,透射电镜观察2组患者腹直肌线粒体超微结构变化.结果 共48例患者完成试验(口服碳水化合物组和口服安慰剂组各24例),口服安慰剂组和口服碳水化合物组术后胰岛素抵抗指数分别为12.68±3.13和5.67±1.40(t=6.646,P=0.003);静息能量分别为(1458±169)、(1341±110) kcal/d(t=2.851,P=0.046);呼吸商分别为0.73 ±0.42和0.79 ±0.22(t=6.546,P=0.041);血三酰甘油水平分别为(0.53±0.24)、(1.04±0.97)g/L(t =2.542,P=0.006);腹直肌线粒体损伤指数分别为1.14 ±0.33和0.92 ±0.19(t =2.730,P=0.028),差异均有统计学意义.口服安慰剂组术后线粒体较术前明显肿胀,嵴膜不清晰.结论 术前口服碳水化合物可降低胃癌根治术患者术后胰岛素抵抗,减少静息能量消耗,改善物质代谢;可能机制与口服碳水化合物促进胰岛素释放,保护线粒体功能有关.
目的 評價胃癌患者術前口服碳水化閤物對術後胰島素牴抗的影響併探討其可能機製.方法 將2011年4-10月連續入院且符閤入組標準的60例胃癌患者按照隨機雙盲原則分為口服碳水化閤物組和口服安慰劑組,術前4h鑑測患者靜息能量消耗(REE)及呼吸商,併抽取空腹血,測定血糖、胰島素及三酰甘油,痳醉前2~3h口服500 ml碳水化閤物(或安慰劑),2組患者均在硬膜外加靜脈複閤全身痳醉下行根治性遠耑胃癌切除術,開腹即刻及關腹前取腹直肌組織併固定,術後即刻抽血測定血糖、胰島素及三酰甘油,併鑑測術後REE及呼吸商,比較2組患者手術前後胰島素牴抗指數、三酰甘油、REE及呼吸商的變化,透射電鏡觀察2組患者腹直肌線粒體超微結構變化.結果 共48例患者完成試驗(口服碳水化閤物組和口服安慰劑組各24例),口服安慰劑組和口服碳水化閤物組術後胰島素牴抗指數分彆為12.68±3.13和5.67±1.40(t=6.646,P=0.003);靜息能量分彆為(1458±169)、(1341±110) kcal/d(t=2.851,P=0.046);呼吸商分彆為0.73 ±0.42和0.79 ±0.22(t=6.546,P=0.041);血三酰甘油水平分彆為(0.53±0.24)、(1.04±0.97)g/L(t =2.542,P=0.006);腹直肌線粒體損傷指數分彆為1.14 ±0.33和0.92 ±0.19(t =2.730,P=0.028),差異均有統計學意義.口服安慰劑組術後線粒體較術前明顯腫脹,嵴膜不清晰.結論 術前口服碳水化閤物可降低胃癌根治術患者術後胰島素牴抗,減少靜息能量消耗,改善物質代謝;可能機製與口服碳水化閤物促進胰島素釋放,保護線粒體功能有關.
목적 평개위암환자술전구복탄수화합물대술후이도소저항적영향병탐토기가능궤제.방법 장2011년4-10월련속입원차부합입조표준적60례위암환자안조수궤쌍맹원칙분위구복탄수화합물조화구복안위제조,술전4h감측환자정식능량소모(REE)급호흡상,병추취공복혈,측정혈당、이도소급삼선감유,마취전2~3h구복500 ml탄수화합물(혹안위제),2조환자균재경막외가정맥복합전신마취하행근치성원단위암절제술,개복즉각급관복전취복직기조직병고정,술후즉각추혈측정혈당、이도소급삼선감유,병감측술후REE급호흡상,비교2조환자수술전후이도소저항지수、삼선감유、REE급호흡상적변화,투사전경관찰2조환자복직기선립체초미결구변화.결과 공48례환자완성시험(구복탄수화합물조화구복안위제조각24례),구복안위제조화구복탄수화합물조술후이도소저항지수분별위12.68±3.13화5.67±1.40(t=6.646,P=0.003);정식능량분별위(1458±169)、(1341±110) kcal/d(t=2.851,P=0.046);호흡상분별위0.73 ±0.42화0.79 ±0.22(t=6.546,P=0.041);혈삼선감유수평분별위(0.53±0.24)、(1.04±0.97)g/L(t =2.542,P=0.006);복직기선립체손상지수분별위1.14 ±0.33화0.92 ±0.19(t =2.730,P=0.028),차이균유통계학의의.구복안위제조술후선립체교술전명현종창,척막불청석.결론 술전구복탄수화합물가강저위암근치술환자술후이도소저항,감소정식능량소모,개선물질대사;가능궤제여구복탄수화합물촉진이도소석방,보호선립체공능유관.
Objective To investigate the effects and mechanism of postoperative insulin resistance in gastrectomy patients with preoperative oral carbohydrate.Methods From April to October 2011,60 consecutive gastric cancer patients met inclusion criteria were divided into oral carbohydrate group and placebo group by randomized double-blind principles.Resting energy expenditure (REE),fasting blood glucose,insulin and triglyceride level were detected in 4 hours preoperatively.The 500 ml carbohydrate or placebo were administrated orally 2-3 hours before anaesthesia.Two group patients underwent radical distal subtotal gastrectomy under epidural compounded intravenous anesthesia.After laparotomy and before the abdomen was closed,a piece of rectus abdominis was taken and fixed in 3% glutaraldehyde.REE,fasting blood glucose,insulin and triglyceride level were detected immediately after surgery.The changes of insulin resistance index,blood triglycerides level,REE and respiratory quotient were compared pre-and postoperatively.The changes of rectus abdominis mitochondrial ultrastructure were observed by transmission electron microscopy respectively.Results There were 48 patients (34 males and 14 females) completed the trial.The 24 and 24 patients in oral placebo and carbohydrate groups respectively.In oral placebo group,post-operative insulin resistance index,REE,respiratory quotient,serum triglyceride level and the rectus abdominis mitochondrial damage index were 12.68 ± 3.13,(1458 ± 169) kcal/d,0.73 ± 0.42,(0.53 ± 0.24) g/L and 1.14 ± 0.33,respectively.And the above items were 5.67 ± 1.40,(1341 ± 110) kcal/d,0.79 ± 0.22,(1.04 ± 0.97) g/L and 0.92 ± 0.19 in oral carbohydrate groups respectively.All difference was statistically significant (t = 6.646,2.851,6.546,2.542 and 2.730,all P < 0.05).Oral placebo group showed a markedly swollen mitochondria,steep membrane was not clear,mitochondria appeared vacuolated changes.Conclusions Preoperative oral carbohydrate could reduce the insulin resistance and REE,improve the material metabolism status in radical gastrectomy patients.The possible mechanisms should be related to promotion of insulin release and protection of mitochondrial function.